Trial intelligence / Profile preview

Low-dose Esmolol for Myocardial Injury in Elderly Frail Patients

NCT05635877Phase 4Recruiting

Start
Feb 2023
Primary completion
Nov 2026
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of esmolol in Myocardial injury. Started Feb 2023; status: recruiting.

02

Drugs

esmolol
03

Conditions

Myocardial injury

Beyond the preview

Go deeper on NCT05635877.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05635877.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call